Evidence map›Paper›PMID 26622577›Full record

ArticleOncology letters2015

Assessment of cell proliferation in renal cell carcinoma using dual-phase

Rei Onishi, Masanori Noguchi, Hayato Kaida, Fukuko Moriya, Katsuaki Chikui, Seiji Kurata, Akihiko Kawahara, Masayoshi Kage, Masatoshi Ishibashi, Kei Matsuoka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. A prospective study on dual timeBMC research notes · 2018
    Article
  4. Japanese journal of radiology · 2018
    Article
  5. Article
  6. PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.Indian journal of urology : IJU : journal of the Urological Society of India
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rei OnishiDepartment of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Masanori NoguchiDepartment of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan ; Clinical Research Division, Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Hayato KaidaDivision of Nuclear Medicine, PET Center and Department of Radiology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Fukuko MoriyaDepartment of Pathology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Katsuaki ChikuiDepartment of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Seiji KurataDivision of Nuclear Medicine, PET Center and Department of Radiology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Akihiko KawaharaDepartment of Pathology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Masayoshi KageDepartment of Pathology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Masatoshi IshibashiDivision of Nuclear Medicine, PET Center and Department of Radiology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Kei MatsuokaDepartment of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to examine the association between

Indexed as

18F-fluorodeoxyglucosecell proliferationKi-67minichromosome maintenance 2positron emission tomography/computed tomographyrenal cell carcinomatopoisomerase IIα

Identifiers

PMID26622577
PMCPMC4509063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.